Yongbin Lin
Impact in
- Oncology top 5%
- Viral-associated cancers and disorders
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Metastasis and carcinoma case studies
Papers in
-
- Lung Cancer Diagnosis and Treatment 16
- Lung Cancer Treatments and Mutations 9
- Ferroptosis and cancer prognosis 3
- Oncology 19
- Viral-associated cancers and disorders 7
- Inflammatory Biomarkers in Disease Prognosis 6
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Ying Liang (14 shared papers)Hao Long (23 shared papers)Tiehua Rong (9 shared papers)Liang Wang (4 shared papers)Hui‐Lan Rao (5 shared papers)Dongrong Situ (8 shared papers)Lanjun Zhang (15 shared papers)Xiangyang Yu (11 shared papers)
- Journals
- Translational Lung Cancer Research (5 papers)Frontiers in Oncology (3 papers)PLoS ONE (2 papers)Annals of Translational Medicine (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yongbin Lin
61 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 77
- Oncology 515
- Pulmonary and Respiratory Medicine 487
- Cancer Research 86
- Otorhinolaryngology 22
- Pathology and Forensic Medicine 85
Countries citing papers authored by Yongbin Lin
This map shows the geographic impact of Yongbin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongbin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongbin Lin more than expected).
Fields of papers citing papers by Yongbin Lin
This network shows the impact of papers produced by Yongbin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongbin Lin. The network helps show where Yongbin Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Yongbin Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 111 | |
| 2 | 2017 | 88 | |
| 3 | 2014 | 79 | |
| 4 | 2021 | 77 | |
| 5 | 2018 | 55 | |
| 6 | 2017 | 48 | |
| 7 | 2013 | 43 | |
| 8 | 2016 | 39 | |
| 9 | 2020 | 37 | |
| 10 | 2015 | 34 | |
| 11 | 2018 | 30 | |
| 12 | 2013 | 29 | |
| 13 | 2015 | 29 | |
| 14 | 2015 | 28 | |
| 15 | 2013 | 28 | |
| 16 | 2012 | 28 | |
| 17 | 2015 | 26 | |
| 18 | 2015 | 24 | |
| 19 | 2013 | 24 | |
| 20 | 2015 | 21 |
About Yongbin Lin
Yongbin Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Surgery and Molecular Biology, having authored 64 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (9 papers), Viral-associated cancers and disorders (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Cancer Genomics and Diagnostics (4 papers), Ferroptosis and cancer prognosis (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Oncology (515 citations), Pulmonary and Respiratory Medicine (487 citations), Cancer Research (86 citations), Otorhinolaryngology (22 citations) and Pathology and Forensic Medicine (85 citations). Yongbin Lin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ying Liang, Hao Long, Tiehua Rong, Liang Wang, Hui‐Lan Rao, Dongrong Situ, Lanjun Zhang, Xiangyang Yu, Hui Liu and Long Jiang. Their work appears in journals such as Translational Lung Cancer Research, Frontiers in Oncology, PLoS ONE, Annals of Translational Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.